IHS Chemical Week

People & Business :: M&A

DSM looking at options to exit its caprolactam business

8:51 AM MDT | July 3, 2013 | Natasha Alperowicz

DSM today declined to comment on a Bloomberg report that it is considering exiting the caprolactam business. However, it confirmed previously announced plans to reduce its exposure to the merchant caprolactam market. “DSM is considering various options and has nothing new to report to its previous public statements,” the company said.   DSM is among the world’s largest merchant sellers of caprolactam, with about 60% of its production at Geelen, Netherlands, and Augusta, GA, being sold to third parties. In addition, a joint venture with...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa